Literature DB >> 19280284

Signet ring cell carcinoma of the appendix manifesting as colonic obstruction and ovarian tumors: report of a case.

Jun Suzuki1, Shinsuke Kazama, Joji Kitayama, Hiroshi Uozaki, Tetsuro Miyata, Hirokazu Nagawa.   

Abstract

Appendiceal cancer is rare and associated with a poor prognosis because it is usually found at an advanced stage. We report a case of appendiceal adenocarcinoma manifesting as a colonic obstruction with a lower abdominal mass. Laparotomy revealed bilateral ovarian tumors and a small appendiceal tumor with peritoneal metastases. We performed ileocecal resection, colectomy, and oophorectomy, following which a histological diagnosis of signet ring cell carcinoma was made. Immunohistochemical analysis revealed positive expression of cytokeratin 7 and 20, and mucin core protein 2 (MUC2), compatible with appendiceal cancer and Kruckenberg metastases. When a patient is found to have disseminated pelvic signet ring cell carcinoma of unknown origin, the appendix should be considered as a possible primary site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280284     DOI: 10.1007/s00595-008-3839-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998.

Authors:  Margaret E McCusker; Timothy R Coté; Limin X Clegg; Leslie H Sobin
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

2.  Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix.

Authors:  Nobuhisa Yajima; Ryuichi Wada; Shin-Ichiro Yamagishi; Hiroki Mizukami; Chieko Itabashi; Soroku Yagihashi
Journal:  Hum Pathol       Date:  2005-11       Impact factor: 3.466

3.  The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites.

Authors:  B M Ronnett; R J Kurman; B M Shmookler; P H Sugarbaker; R H Young
Journal:  Am J Surg Pathol       Date:  1997-10       Impact factor: 6.394

4.  The natural history of surgically treated primary adenocarcinoma of the appendix.

Authors:  S S Nitecki; B G Wolff; R Schlinkert; M G Sarr
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

5.  Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary.

Authors:  C C Wauters; F Smedts; L G Gerrits; F T Bosman; F C Ramaekers
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

6.  Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.

Authors:  T S Loy; R D Calaluce; G L Keeney
Journal:  Mod Pathol       Date:  1996-11       Impact factor: 7.842

7.  Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.

Authors:  Hong Feng; Mohammad Ghazizadeh; Hideki Konishi; Tsutomu Araki
Journal:  Jpn J Clin Oncol       Date:  2002-12       Impact factor: 3.019

8.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

Authors:  R Moll; A Löwe; J Laufer; W W Franke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

9.  Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.

Authors:  Russell Vang; Allen M Gown; Chengquan Zhao; Todd S Barry; Christina Isacson; Mary S Richardson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2007-06       Impact factor: 6.394

10.  Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns.

Authors:  R Moll; D L Schiller; W W Franke
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

View more
  6 in total

1.  Jejunal cancer detected after a resection of bilateral ovarian metastasis: report of a case.

Authors:  Hiroshi Maekawa; Koichi Sato; Yoshihiro Komatsu; Hajime Orita; Mutsumi Sakurada
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

2.  An Unusual Progression of Signet-Ring Cell Carcinoma of the Appendix in a Caucasian Woman.

Authors:  Katelynn Davis; Andrew M Bellizzi; Carlos H F Chan
Journal:  J Gastrointest Cancer       Date:  2019-06

3.  Peritoneal seeding from appendiceal carcinoma: A case report and review of the literature.

Authors:  Valentina R Bertuzzo; Federico Coccolini; Antonio D Pinna
Journal:  World J Gastrointest Surg       Date:  2010-08-27

4.  Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals.

Authors:  Toshiyuki Kitai; Masahiro Kawashima; Kenya Yamanaka; Kunio Ichijima; Hideaki Fujii; Susumu Mashima; Yasuyuki Shimahara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

5.  Appendiceal Carcinoma with Krukenberg's Tumour Mimicking Primary Ovarian Cancer.

Authors:  Clement Wilfred D; Vijaya Mysorekar V; Sulatha Kamath; Saurabh Singla
Journal:  J Clin Diagn Res       Date:  2013-08-01

6.  A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor.

Authors:  Hiroaki Shibahara; Michiyo Higashi; Seiya Yokoyama; Karine Rousseau; Iwao Kitazono; Masahiko Osako; Hiroshi Shirahama; Yukie Tashiro; Yasuhiro Kurumiya; Michihiko Narita; Shingo Kuze; Hiroshi Hasagawa; Takehito Kato; Hitoshi Kubota; Hideaki Suzuki; Toshiyuki Arai; Yu Sakai; Norihiro Yuasa; Masahiko Fujino; Shinji Kondo; Yoshichika Okamoto; Tatsuyoshi Yamamoto; Takashi Hiromatsu; Eiji Sasaki; Kazuhisa Shirai; Satoru Kawai; Koutarou Hattori; Hideki Tsuji; Osamu Okochi; Masaki Sakamoto; Akinobu Kondo; Naomi Konishi; Surinder K Batra; Suguru Yonezawa
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.